IRWD : Summary for Ironwood Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets close in 3 hrs 9 mins

Ironwood Pharmaceuticals, Inc. (IRWD)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.23+0.09 (+0.53%)
As of 12:51PM EDT. Market open.
People also watch
INFIAEGRRPTPSGYPMNTA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close17.14
Open16.70
Bid17.18 x 600
Ask17.19 x 900
Day's Range16.70 - 17.26
52 Week Range9.06 - 18.53
Volume349,573
Avg. Volume1,377,286
Market Cap2.55B
Beta1.45
PE Ratio (TTM)-30.55
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017
    Capital Cube10 days ago

    Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017

    Categories: Yahoo Finance Get free summary analysis Ironwood Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Ironwood Pharmaceuticals, Inc. – Progenics Pharmaceuticals, Inc., Nektar Therapeutics, Astrazeneca PLC Sponsored ADR, Sucampo Pharmaceuticals, Inc. Class A, Cumberland Pharmaceuticals Inc. and Synthetic Biologics, Inc. (PGNX-US, NKTR-US, AZN-US, ... Read more (Read more...)

  • Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
    Capital Cube13 days ago

    Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017

    Categories: Yahoo Finance Get free summary analysis Ironwood Pharmaceuticals, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Ironwood Pharmaceuticals, Inc. – Progenics Pharmaceuticals, Inc., Nektar Therapeutics, Astrazeneca PLC Sponsored ADR, Sucampo Pharmaceuticals, Inc. Class A, Cumberland Pharmaceuticals Inc. and Synthetic Biologics, Inc. (PGNX-US, NKTR-US, AZN-US, ... Read more (Read more...)

  • Synergy Pharmaceuticals: Approval, Now What?
    Motley Fool14 days ago

    Synergy Pharmaceuticals: Approval, Now What?

    Is Synergy a buy on the post-approval dip?